nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2E1—Parkinson's disease	0.591	1	CbGaD
Bromazepam—GABRR3—peripheral nervous system—Parkinson's disease	0.00851	0.0469	CbGeAlD
Bromazepam—GABRR2—peripheral nervous system—Parkinson's disease	0.00738	0.0407	CbGeAlD
Bromazepam—GABRR1—peripheral nervous system—Parkinson's disease	0.0071	0.0392	CbGeAlD
Bromazepam—GABRQ—nerve—Parkinson's disease	0.00663	0.0366	CbGeAlD
Bromazepam—GABRR3—nerve—Parkinson's disease	0.00663	0.0366	CbGeAlD
Bromazepam—GABRR2—nerve—Parkinson's disease	0.00575	0.0317	CbGeAlD
Bromazepam—GABRR1—nerve—Parkinson's disease	0.00554	0.0305	CbGeAlD
Bromazepam—GABRA6—hindbrain—Parkinson's disease	0.00345	0.019	CbGeAlD
Bromazepam—GABRQ—forebrain—Parkinson's disease	0.00275	0.0152	CbGeAlD
Bromazepam—GABRB2—hindbrain—Parkinson's disease	0.00254	0.014	CbGeAlD
Bromazepam—GABRA2—hindbrain—Parkinson's disease	0.00232	0.0128	CbGeAlD
Bromazepam—GABRR1—forebrain—Parkinson's disease	0.00229	0.0127	CbGeAlD
Bromazepam—GABRA1—hindbrain—Parkinson's disease	0.00224	0.0124	CbGeAlD
Bromazepam—GABRD—forebrain—Parkinson's disease	0.00199	0.011	CbGeAlD
Bromazepam—GABRA6—brainstem—Parkinson's disease	0.00198	0.0109	CbGeAlD
Bromazepam—GABRG1—forebrain—Parkinson's disease	0.00192	0.0106	CbGeAlD
Bromazepam—GABRA5—forebrain—Parkinson's disease	0.00185	0.0102	CbGeAlD
Bromazepam—GABRA4—forebrain—Parkinson's disease	0.00168	0.00926	CbGeAlD
Bromazepam—GABRR3—head—Parkinson's disease	0.00157	0.00868	CbGeAlD
Bromazepam—GABRQ—head—Parkinson's disease	0.00157	0.00868	CbGeAlD
Bromazepam—GABRR3—nervous system—Parkinson's disease	0.00149	0.00823	CbGeAlD
Bromazepam—GABRQ—nervous system—Parkinson's disease	0.00149	0.00823	CbGeAlD
Bromazepam—GABRB2—brainstem—Parkinson's disease	0.00145	0.00803	CbGeAlD
Bromazepam—GABRD—medulla oblongata—Parkinson's disease	0.00144	0.00794	CbGeAlD
Bromazepam—GABRQ—central nervous system—Parkinson's disease	0.00144	0.00792	CbGeAlD
Bromazepam—GABRB2—forebrain—Parkinson's disease	0.0014	0.00775	CbGeAlD
Bromazepam—GABRG2—forebrain—Parkinson's disease	0.0014	0.00775	CbGeAlD
Bromazepam—GABRG1—medulla oblongata—Parkinson's disease	0.00139	0.00765	CbGeAlD
Bromazepam—GABRG3—head—Parkinson's disease	0.00138	0.0076	CbGeAlD
Bromazepam—GABRR2—head—Parkinson's disease	0.00136	0.00753	CbGeAlD
Bromazepam—GABRB1—medulla oblongata—Parkinson's disease	0.00134	0.00742	CbGeAlD
Bromazepam—GABRA2—brainstem—Parkinson's disease	0.00133	0.00733	CbGeAlD
Bromazepam—GABRD—midbrain—Parkinson's disease	0.00132	0.00726	CbGeAlD
Bromazepam—GABRR1—head—Parkinson's disease	0.00131	0.00725	CbGeAlD
Bromazepam—GABRG3—nervous system—Parkinson's disease	0.00131	0.00721	CbGeAlD
Bromazepam—GABRR2—nervous system—Parkinson's disease	0.00129	0.00714	CbGeAlD
Bromazepam—GABRA1—brainstem—Parkinson's disease	0.00128	0.00709	CbGeAlD
Bromazepam—GABRA2—forebrain—Parkinson's disease	0.00128	0.00708	CbGeAlD
Bromazepam—GABRG1—midbrain—Parkinson's disease	0.00127	0.00699	CbGeAlD
Bromazepam—GABRG3—central nervous system—Parkinson's disease	0.00126	0.00694	CbGeAlD
Bromazepam—GABRR1—nervous system—Parkinson's disease	0.00125	0.00687	CbGeAlD
Bromazepam—GABRA1—forebrain—Parkinson's disease	0.00124	0.00684	CbGeAlD
Bromazepam—GABRG1—spinal cord—Parkinson's disease	0.00124	0.00682	CbGeAlD
Bromazepam—GABRB1—midbrain—Parkinson's disease	0.00123	0.00678	CbGeAlD
Bromazepam—GABRR2—cerebellum—Parkinson's disease	0.00122	0.00672	CbGeAlD
Bromazepam—GABRR1—central nervous system—Parkinson's disease	0.0012	0.00661	CbGeAlD
Bromazepam—GABRB1—spinal cord—Parkinson's disease	0.0012	0.00661	CbGeAlD
Bromazepam—GABRD—head—Parkinson's disease	0.00114	0.0063	CbGeAlD
Bromazepam—GABRQ—brain—Parkinson's disease	0.00114	0.00629	CbGeAlD
Bromazepam—GABRG1—head—Parkinson's disease	0.0011	0.00606	CbGeAlD
Bromazepam—GABRA6—head—Parkinson's disease	0.00109	0.00603	CbGeAlD
Bromazepam—GABRD—nervous system—Parkinson's disease	0.00108	0.00597	CbGeAlD
Bromazepam—GABRB3—forebrain—Parkinson's disease	0.00108	0.00595	CbGeAlD
Bromazepam—GABRB1—head—Parkinson's disease	0.00107	0.00588	CbGeAlD
Bromazepam—GABRA5—head—Parkinson's disease	0.00106	0.00585	CbGeAlD
Bromazepam—GABRD—central nervous system—Parkinson's disease	0.00104	0.00575	CbGeAlD
Bromazepam—GABRG1—nervous system—Parkinson's disease	0.00104	0.00575	CbGeAlD
Bromazepam—GABRA6—nervous system—Parkinson's disease	0.00104	0.00571	CbGeAlD
Bromazepam—GABRD—cerebellum—Parkinson's disease	0.00102	0.00562	CbGeAlD
Bromazepam—GABRG2—medulla oblongata—Parkinson's disease	0.00101	0.0056	CbGeAlD
Bromazepam—GABRB2—medulla oblongata—Parkinson's disease	0.00101	0.0056	CbGeAlD
Bromazepam—GABRB1—nervous system—Parkinson's disease	0.00101	0.00557	CbGeAlD
Bromazepam—GABRA5—nervous system—Parkinson's disease	0.001	0.00554	CbGeAlD
Bromazepam—GABRG1—central nervous system—Parkinson's disease	0.001	0.00553	CbGeAlD
Bromazepam—GABRG3—brain—Parkinson's disease	0.000999	0.00551	CbGeAlD
Bromazepam—GABRA6—central nervous system—Parkinson's disease	0.000997	0.0055	CbGeAlD
Bromazepam—GABRA3—head—Parkinson's disease	0.000986	0.00544	CbGeAlD
Bromazepam—GABRG1—cerebellum—Parkinson's disease	0.00098	0.00541	CbGeAlD
Bromazepam—GABRA6—cerebellum—Parkinson's disease	0.000974	0.00538	CbGeAlD
Bromazepam—GABRB1—central nervous system—Parkinson's disease	0.000972	0.00536	CbGeAlD
Bromazepam—GABRA5—central nervous system—Parkinson's disease	0.000967	0.00534	CbGeAlD
Bromazepam—GABRA4—head—Parkinson's disease	0.000961	0.0053	CbGeAlD
Bromazepam—GABRP—head—Parkinson's disease	0.000954	0.00526	CbGeAlD
Bromazepam—GABRR1—brain—Parkinson's disease	0.000952	0.00525	CbGeAlD
Bromazepam—GABRB1—cerebellum—Parkinson's disease	0.00095	0.00524	CbGeAlD
Bromazepam—GABRA3—nervous system—Parkinson's disease	0.000935	0.00516	CbGeAlD
Bromazepam—GABRG2—midbrain—Parkinson's disease	0.000927	0.00512	CbGeAlD
Bromazepam—GABRB2—midbrain—Parkinson's disease	0.000927	0.00512	CbGeAlD
Bromazepam—GABRA4—nervous system—Parkinson's disease	0.000911	0.00503	CbGeAlD
Bromazepam—GABRG2—spinal cord—Parkinson's disease	0.000905	0.00499	CbGeAlD
Bromazepam—GABRB2—spinal cord—Parkinson's disease	0.000905	0.00499	CbGeAlD
Bromazepam—GABRA3—central nervous system—Parkinson's disease	0.0009	0.00497	CbGeAlD
Bromazepam—GABRA1—medulla oblongata—Parkinson's disease	0.000896	0.00494	CbGeAlD
Bromazepam—GABRA4—central nervous system—Parkinson's disease	0.000877	0.00484	CbGeAlD
Bromazepam—GABRA4—cerebellum—Parkinson's disease	0.000858	0.00473	CbGeAlD
Bromazepam—GABRD—brain—Parkinson's disease	0.000827	0.00456	CbGeAlD
Bromazepam—GABRA1—midbrain—Parkinson's disease	0.000819	0.00452	CbGeAlD
Bromazepam—GABRG2—head—Parkinson's disease	0.000804	0.00444	CbGeAlD
Bromazepam—GABRB2—head—Parkinson's disease	0.000804	0.00444	CbGeAlD
Bromazepam—GABRA1—spinal cord—Parkinson's disease	0.000799	0.00441	CbGeAlD
Bromazepam—GABRG1—brain—Parkinson's disease	0.000796	0.00439	CbGeAlD
Bromazepam—GABRA6—brain—Parkinson's disease	0.000791	0.00437	CbGeAlD
Bromazepam—GABRB3—medulla oblongata—Parkinson's disease	0.000779	0.0043	CbGeAlD
Bromazepam—GABRB1—brain—Parkinson's disease	0.000772	0.00426	CbGeAlD
Bromazepam—GABRA5—brain—Parkinson's disease	0.000768	0.00424	CbGeAlD
Bromazepam—GABRG2—nervous system—Parkinson's disease	0.000762	0.00421	CbGeAlD
Bromazepam—GABRB2—nervous system—Parkinson's disease	0.000762	0.00421	CbGeAlD
Bromazepam—GABRA2—head—Parkinson's disease	0.000735	0.00405	CbGeAlD
Bromazepam—GABRG2—central nervous system—Parkinson's disease	0.000734	0.00405	CbGeAlD
Bromazepam—GABRB2—central nervous system—Parkinson's disease	0.000734	0.00405	CbGeAlD
Bromazepam—GABRE—head—Parkinson's disease	0.000728	0.00402	CbGeAlD
Bromazepam—GABRG2—cerebellum—Parkinson's disease	0.000717	0.00396	CbGeAlD
Bromazepam—GABRB2—cerebellum—Parkinson's disease	0.000717	0.00396	CbGeAlD
Bromazepam—GABRA3—brain—Parkinson's disease	0.000715	0.00394	CbGeAlD
Bromazepam—GABRB3—midbrain—Parkinson's disease	0.000712	0.00393	CbGeAlD
Bromazepam—GABRA1—head—Parkinson's disease	0.00071	0.00392	CbGeAlD
Bromazepam—GABRA4—brain—Parkinson's disease	0.000697	0.00384	CbGeAlD
Bromazepam—GABRA2—nervous system—Parkinson's disease	0.000696	0.00384	CbGeAlD
Bromazepam—GABRB3—spinal cord—Parkinson's disease	0.000695	0.00383	CbGeAlD
Bromazepam—GABRE—nervous system—Parkinson's disease	0.000691	0.00381	CbGeAlD
Bromazepam—GABRA1—nervous system—Parkinson's disease	0.000673	0.00371	CbGeAlD
Bromazepam—GABRA2—central nervous system—Parkinson's disease	0.000671	0.0037	CbGeAlD
Bromazepam—GABRE—central nervous system—Parkinson's disease	0.000665	0.00367	CbGeAlD
Bromazepam—GABRA2—cerebellum—Parkinson's disease	0.000655	0.00362	CbGeAlD
Bromazepam—GABRA1—central nervous system—Parkinson's disease	0.000648	0.00358	CbGeAlD
Bromazepam—GABRA1—cerebellum—Parkinson's disease	0.000633	0.00349	CbGeAlD
Bromazepam—GABRB3—head—Parkinson's disease	0.000617	0.00341	CbGeAlD
Bromazepam—GABRB3—nervous system—Parkinson's disease	0.000585	0.00323	CbGeAlD
Bromazepam—GABRG2—brain—Parkinson's disease	0.000583	0.00321	CbGeAlD
Bromazepam—GABRB2—brain—Parkinson's disease	0.000583	0.00321	CbGeAlD
Bromazepam—CYP2E1—cardiovascular system—Parkinson's disease	0.00058	0.0032	CbGeAlD
Bromazepam—Clonazepam—CYP2E1—Parkinson's disease	0.000575	0.347	CrCbGaD
Bromazepam—GABRB3—central nervous system—Parkinson's disease	0.000564	0.00311	CbGeAlD
Bromazepam—GABRB3—cerebellum—Parkinson's disease	0.000551	0.00304	CbGeAlD
Bromazepam—GABRA2—brain—Parkinson's disease	0.000532	0.00294	CbGeAlD
Bromazepam—GABRE—brain—Parkinson's disease	0.000528	0.00291	CbGeAlD
Bromazepam—GABRA1—brain—Parkinson's disease	0.000514	0.00284	CbGeAlD
Bromazepam—CYP2E1—medulla oblongata—Parkinson's disease	0.000496	0.00273	CbGeAlD
Bromazepam—GABRB3—brain—Parkinson's disease	0.000447	0.00247	CbGeAlD
Bromazepam—CYP2E1—spinal cord—Parkinson's disease	0.000442	0.00244	CbGeAlD
Bromazepam—Nitrazepam—CYP2E1—Parkinson's disease	0.000417	0.251	CrCbGaD
Bromazepam—CYP2E1—head—Parkinson's disease	0.000393	0.00217	CbGeAlD
Bromazepam—CYP2E1—nervous system—Parkinson's disease	0.000372	0.00205	CbGeAlD
Bromazepam—CYP2E1—central nervous system—Parkinson's disease	0.000359	0.00198	CbGeAlD
Bromazepam—CYP2E1—cerebellum—Parkinson's disease	0.00035	0.00193	CbGeAlD
Bromazepam—CYP3A4—nervous system—Parkinson's disease	0.0003	0.00165	CbGeAlD
Bromazepam—Diazepam—CYP2E1—Parkinson's disease	0.000294	0.177	CrCbGaD
Bromazepam—CYP3A4—central nervous system—Parkinson's disease	0.000289	0.00159	CbGeAlD
Bromazepam—CYP2E1—brain—Parkinson's disease	0.000285	0.00157	CbGeAlD
Bromazepam—Nitrazepam—ABCB1—Parkinson's disease	0.000219	0.132	CrCbGaD
Bromazepam—Diazepam—ABCB1—Parkinson's disease	0.000154	0.093	CrCbGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.85e-05	0.000436	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	9.85e-05	0.000436	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.79e-05	0.000433	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	9.67e-05	0.000428	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.61e-05	0.000425	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	9.6e-05	0.000425	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.55e-05	0.000422	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.55e-05	0.000422	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	9.4e-05	0.000416	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	9.23e-05	0.000408	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	9.12e-05	0.000403	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	9.07e-05	0.000401	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	9.01e-05	0.000398	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	9.01e-05	0.000398	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	8.85e-05	0.000391	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	8.78e-05	0.000388	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	8.74e-05	0.000387	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	8.71e-05	0.000385	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	8.7e-05	0.000385	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.7e-05	0.000385	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	8.65e-05	0.000383	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.58e-05	0.000379	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—COMT—Parkinson's disease	8.55e-05	0.000378	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	8.51e-05	0.000376	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	8.49e-05	0.000375	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	8.43e-05	0.000373	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.4e-05	0.000372	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	8.39e-05	0.000371	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.35e-05	0.000369	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.3e-05	0.000367	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.3e-05	0.000367	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	8.25e-05	0.000365	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.19e-05	0.000362	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.06e-05	0.000357	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	8.03e-05	0.000355	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.96e-05	0.000352	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.96e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	7.96e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	7.9e-05	0.000349	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.86e-05	0.000348	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.85e-05	0.000347	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	7.82e-05	0.000346	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	7.79e-05	0.000344	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.74e-05	0.000342	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	7.73e-05	0.000342	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	7.71e-05	0.000341	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.63e-05	0.000337	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	7.58e-05	0.000335	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.53e-05	0.000333	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	7.41e-05	0.000328	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.33e-05	0.000324	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.28e-05	0.000322	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.23e-05	0.00032	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	7.08e-05	0.000313	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	7.04e-05	0.000311	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.89e-05	0.000305	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.83e-05	0.000302	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	6.78e-05	0.0003	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.73e-05	0.000298	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.7e-05	0.000296	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.69e-05	0.000296	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.65e-05	0.000294	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.64e-05	0.000294	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.62e-05	0.000293	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—COMT—Parkinson's disease	6.59e-05	0.000292	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.57e-05	0.000291	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	6.56e-05	0.00029	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.56e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	6.55e-05	0.00029	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	6.5e-05	0.000288	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	6.47e-05	0.000286	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.46e-05	0.000286	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.46e-05	0.000286	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.43e-05	0.000284	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.42e-05	0.000284	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.37e-05	0.000282	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.31e-05	0.000279	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.3e-05	0.000279	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.29e-05	0.000278	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.2e-05	0.000274	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	6.2e-05	0.000274	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.16e-05	0.000273	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.11e-05	0.00027	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.11e-05	0.00027	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.05e-05	0.000268	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.04e-05	0.000267	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	6.03e-05	0.000267	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	5.95e-05	0.000263	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.75e-05	0.000254	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	5.67e-05	0.000251	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.59e-05	0.000247	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ND3—Parkinson's disease	5.54e-05	0.000245	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MCCC1—Parkinson's disease	5.54e-05	0.000245	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.52e-05	0.000244	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.51e-05	0.000244	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.49e-05	0.000243	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.39e-05	0.000238	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.36e-05	0.000237	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.36e-05	0.000237	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.29e-05	0.000234	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.27e-05	0.000233	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.26e-05	0.000233	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	5.23e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—OMD—Parkinson's disease	5.21e-05	0.00023	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TALDO1—Parkinson's disease	5.21e-05	0.00023	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.18e-05	0.000229	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.16e-05	0.000228	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.14e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—COMT—Parkinson's disease	5.14e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	5.14e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	5.14e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	5.11e-05	0.000226	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	5.1e-05	0.000226	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	5.07e-05	0.000224	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.05e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	5.04e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	4.94e-05	0.000218	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.83e-05	0.000214	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.78e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.72e-05	0.000209	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GCH1—Parkinson's disease	4.71e-05	0.000208	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	4.7e-05	0.000208	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	4.63e-05	0.000205	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.6e-05	0.000203	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.54e-05	0.000201	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.41e-05	0.000195	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ND3—Parkinson's disease	4.28e-05	0.000189	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MCCC1—Parkinson's disease	4.28e-05	0.000189	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FBP1—Parkinson's disease	4.2e-05	0.000186	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—DBH—Parkinson's disease	4.2e-05	0.000186	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GBA—Parkinson's disease	4.2e-05	0.000186	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TALDO1—Parkinson's disease	4.02e-05	0.000178	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—OMD—Parkinson's disease	4.02e-05	0.000178	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.96e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.95e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.94e-05	0.000174	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.91e-05	0.000173	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.9e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.89e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	3.81e-05	0.000169	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GCH1—Parkinson's disease	3.64e-05	0.000161	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.63e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.58e-05	0.000158	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.54e-05	0.000156	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ND3—Parkinson's disease	3.33e-05	0.000147	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MCCC1—Parkinson's disease	3.33e-05	0.000147	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.28e-05	0.000145	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GBA—Parkinson's disease	3.24e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FBP1—Parkinson's disease	3.24e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—DBH—Parkinson's disease	3.24e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—OMD—Parkinson's disease	3.13e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.13e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—DDC—Parkinson's disease	3.08e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.97e-05	0.000131	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.91e-05	0.000129	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.83e-05	0.000125	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.62e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.59e-05	0.000115	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.57e-05	0.000114	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ND3—Parkinson's disease	2.57e-05	0.000114	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.55e-05	0.000113	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DBH—Parkinson's disease	2.52e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.52e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GBA—Parkinson's disease	2.52e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.42e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—OMD—Parkinson's disease	2.42e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.29e-05	0.000101	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.25e-05	9.93e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.22e-05	9.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.19e-05	9.67e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	8.94e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MAOB—Parkinson's disease	2e-05	8.85e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.95e-05	8.62e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GBA—Parkinson's disease	1.95e-05	8.62e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DBH—Parkinson's disease	1.95e-05	8.62e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.93e-05	8.53e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.91e-05	8.43e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.89e-05	8.37e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DDC—Parkinson's disease	1.85e-05	8.2e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.75e-05	7.74e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.74e-05	7.71e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.73e-05	7.64e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TH—Parkinson's disease	1.72e-05	7.6e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.65e-05	7.3e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.58e-05	6.97e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.56e-05	6.9e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.49e-05	6.58e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.48e-05	6.57e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—COMT—Parkinson's disease	1.46e-05	6.46e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.46e-05	6.46e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.45e-05	6.43e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.45e-05	6.42e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.43e-05	6.34e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DDC—Parkinson's disease	1.43e-05	6.32e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.38e-05	6.09e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	6.02e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.35e-05	5.97e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.35e-05	5.95e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.34e-05	5.91e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TH—Parkinson's disease	1.33e-05	5.86e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.28e-05	5.66e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.27e-05	5.63e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.22e-05	5.38e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.2e-05	5.32e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.18e-05	5.22e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	5.13e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.14e-05	5.03e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—COMT—Parkinson's disease	1.13e-05	4.99e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.12e-05	4.96e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.12e-05	4.95e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.11e-05	4.89e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—Parkinson's disease	1.1e-05	4.86e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.06e-05	4.7e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	4.69e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.05e-05	4.64e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TH—Parkinson's disease	1.03e-05	4.57e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.03e-05	4.56e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYCS—Parkinson's disease	9.92e-06	4.39e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPX1—Parkinson's disease	9.88e-06	4.37e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—INS—Parkinson's disease	9.39e-06	4.15e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.11e-06	4.03e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.95e-06	3.96e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—COMT—Parkinson's disease	8.79e-06	3.89e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.78e-06	3.88e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—Parkinson's disease	8.74e-06	3.87e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MAOA—Parkinson's disease	8.72e-06	3.86e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMOX1—Parkinson's disease	8.62e-06	3.81e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—Parkinson's disease	8.48e-06	3.75e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.28e-06	3.66e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.18e-06	3.62e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.09e-06	3.58e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.04e-06	3.55e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TH—Parkinson's disease	7.97e-06	3.53e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPX1—Parkinson's disease	7.69e-06	3.4e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.66e-06	3.39e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—INS—Parkinson's disease	7.25e-06	3.21e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.1e-06	3.14e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—COMT—Parkinson's disease	6.78e-06	3e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.75e-06	2.98e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.73e-06	2.98e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.66e-06	2.94e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—Parkinson's disease	6.61e-06	2.92e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.39e-06	2.83e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.2e-06	2.74e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.94e-06	2.63e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—INS—Parkinson's disease	5.65e-06	2.5e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.48e-06	2.42e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—Parkinson's disease	5.1e-06	2.26e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—INS—Parkinson's disease	4.36e-06	1.93e-05	CbGpPWpGaD
